Intel is soaring after an earnings beat. These two Wall Street firms call the stock a buy

Intel posted Q1 EPS of $0.29 versus $0.01 consensus and revenue of $13.58B versus $12.42B expected, while shares jumped 25% in premarket trading. Evercore and Citi both upgraded the stock after the print, lifting price targets to $111 and $95, respectively, as they cited improving AI-related CPU demand, a stronger balance sheet, and strategic positioning as a leading U.S.-based chip supplier. Citi also said Intel expects its CPU business to grow at a double-digit rate in 2026 and sustain gains in 2027.

Analysis

This is less a one-day sympathy squeeze and more a rerating of Intel from “distressed turnaround” to “strategic national asset.” The market is likely underestimating how much multiple expansion can come from a lower perceived terminal-risk premium: if investors start capitalizing Intel like a policy-backed infrastructure/AI supplier rather than a structurally lossmaking foundry story, the equity can keep compounding even before earnings inflect meaningfully. The clearest second-order winner is domestic semiconductor equipment and packaging vendors that benefit from a more capex-intensive Intel roadmap, while the clearest loser is any legacy perception that the U.S. AI supply chain is fully captive to Nvidia-led accelerators.

The key nuance is that the upside is now more about CPU attach, edge inference, and enterprise/sovereign workloads than hyperscale training. If agentic AI shifts compute mix toward many more general-purpose cores, Intel’s relevance rises at the margin even without displacing Nvidia in training. That creates a longer-duration revenue tail, but also raises the bar: the bull case depends on sustained unit growth and execution discipline over multiple product cycles, not just a single quarter print.

The market may still be too complacent about competitive retaliation. A stronger Intel increases pressure on AMD in server CPUs and on any rival bidding for domestic policy favor, but it also forces Nvidia and hyperscalers to diversify supplier dependencies, which can slow the “winner-take-most” narrative in AI hardware. The main reversal catalyst is not a bad quarter, but a sign that operating leverage stalls or that geopolitical support fails to convert into durable commercial share gains over the next 2-4 quarters.

Consensus likely misses that the stock can stay expensive if it becomes the cleanest U.S. sovereign AI semiconductor proxy. That does not mean the move is risk-free: after a sharp repricing, incremental upside is more sensitive to guidance credibility than to near-term results. The asymmetry now favors selective exposure rather than chasing outright at elevated levels.

Key Decisions for Investors

• Use pullbacks in INTC over the next 1-3 weeks to build a tactical long, but size it as a rerating trade rather than a fundamental core: target 12-18 months, with upside to a continued multiple expansion if execution holds; stop if management guidance slips on 2026/27 unit growth or margin path.
• Pair trade: long INTC / short AMD for 3-6 months to express the view that sovereign AI and enterprise CPU demand can reaccelerate Intel share while AMD faces tougher comparison and valuation sensitivity; risk is if AMD keeps taking incremental server share faster than expected.
• Buy call spreads in INTC 3-6 months out instead of common after the gap higher to define risk; the trade benefits from continued buy-side consensus catch-up, but caps downside if the move proves mostly sentiment-driven.
• Add exposure to U.S.-based semiconductor supply-chain beneficiaries on any Intel pullback, especially equipment, packaging, and domestic manufacturing names; the second-order trade is not just Intel equity beta but higher capex intensity across the onshore ecosystem.
• Trim or hedge any crowded long-nvidia/AI-exceptionality positioning against a modest INTC long, since the market may be starting to price a broader AI hardware stack rather than a single dominant accelerator winner.